ohm: I can assure you, with the utmost regret, tha
Post# of 145825
As previously indicated, all of the above is only my opinion (or guess if you prefer). I have no inside knowledge at either end of the CYDY/FDA equation, I may be wrong and sincerely hope that I am. Be that as it may, I do not share your confidence that some combination of CYDY or third party initiated lawsuits, bureaucratic aversion to negative media publicity, or bureaucratic fear of in house discipline will insure ultimate fair treatment of LL under CYDY ownership.
Any lawsuit against the United States challenging FDA decision making would be incredibly costly, incredibly time consuming, and exceedingly difficult to win, especially in the District of Columbia US District Court. Moreover, from what I have watched on the news in recent years, federal agencies and their employees are not in the least deterred from engaging in indefensible conduct by negative media coverage, especially since only a handful of outlets would even cover any criticism of the current administration. And with regard to bureaucrats fearing unfavorable reviews by supervisors, it is almost impossible to fire anyone working for the governments and even demotions are exceedingly rare.
The hypothesis I have set out does not require some complicated conspiracy to be true, and I think that is unlikely here. Rather, I suspect it simply requires the active intervention of one or more FDA employees or supervisors who have become subject to the influence, for whatever reason, of one or more BP companies who have approved or clinical stage drugs that would compete with LL for sales revenue. The existence of such a situation, if it were in play, would be consistent with the FDA's track record of irrational conduct regarding LL.
So, in the utmost good faith, I remain concerned.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)